Side-by-side comparison of AI visibility scores, market position, and capabilities
Orca Bio is developing high-purity precision cell therapies using proprietary cell sorting technology to improve the safety and outcomes of bone marrow transplantation; raised $270M+; lead programs in AML, MDS, and other blood cancers;
Orca Bio is a Menlo Park, California-based biotechnology company founded in 2016 that is developing next-generation cell therapies for blood cancers and autoimmune diseases through a proprietary high-precision cell sorting and manufacturing platform. The company's core technology enables the production of precisely defined cell therapy products — specifically, highly purified stem cell grafts and engineered immune cell compositions for allogeneic (donor-to-patient) bone marrow transplantation. Unlike conventional bone marrow transplants, which transfer a heterogeneous mixture of cells that can attack the patient's body (graft-versus-host disease, or GVHD), Orca Bio's manufactured grafts are composed of precisely selected cell populations that retain the anti-cancer effect while dramatically reducing the cells responsible for GVHD.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.